-transparent.png){kind=logo}
XPA protein from a patient with typical group A xeroderma pigmentosum (XP) and three atypical group-A XP patients were analysed. Immunoblot analysis of XPA proteins revealed that a typical group-A XP patient showed no XPA protein band, while a smaller, truncated XPA protein, which appears to be responsible for mid skin lesions and minimal neurological abnormalities, was detected in cells from three atypical group-A XP patients. Furthermore, the difference in the amount of truncated XPA protein correlated with the mildness of neurological manifestations in these three atypical group-A XP patients. The results suggest a correlation between clinical manifestations and qualitative and quantitative abnormalities of XPA protein products.
T Mimaki, and
M Nitta, and
M Saijo, and
N Tachi, and
R Minami, and
K Tanaka
May 1987,
No to hattatsu = Brain and development,
T Mimaki, and
M Nitta, and
M Saijo, and
N Tachi, and
R Minami, and
K Tanaka
October 1998,
Nucleic acids research,
T Mimaki, and
M Nitta, and
M Saijo, and
N Tachi, and
R Minami, and
K Tanaka
April 1999,
Molecules and cells,
T Mimaki, and
M Nitta, and
M Saijo, and
N Tachi, and
R Minami, and
K Tanaka
February 2002,
Molecules and cells,
T Mimaki, and
M Nitta, and
M Saijo, and
N Tachi, and
R Minami, and
K Tanaka
October 1995,
Human molecular genetics,
T Mimaki, and
M Nitta, and
M Saijo, and
N Tachi, and
R Minami, and
K Tanaka
September 1996,
The Journal of investigative dermatology,
T Mimaki, and
M Nitta, and
M Saijo, and
N Tachi, and
R Minami, and
K Tanaka
December 2008,
DNA repair,
T Mimaki, and
M Nitta, and
M Saijo, and
N Tachi, and
R Minami, and
K Tanaka
October 2010,
The Journal of investigative dermatology,
T Mimaki, and
M Nitta, and
M Saijo, and
N Tachi, and
R Minami, and
K Tanaka
October 2017,
Journal of medicinal chemistry,
T Mimaki, and
M Nitta, and
M Saijo, and
N Tachi, and
R Minami, and
K Tanaka
February 2008,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
